Lars Ekman is an Executive Partner at Sofinnova Investments with over 30 years in life sciences. He has held senior R&D roles at Elan, Schwarz Pharma, and Pharmacia, and currently chairs Prothena.
What Lars can write
Sofinnova Investments writes $10M to $30M checks, larger than 97% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Sofinnova Investments.Career
- Pharmacia · senior scientific and clinical functions1984-1997
- Schwarz Pharma AG · Executive Vice President, Research and Development1997-2001
- Elan · President of Research and Development2001-2008
- Pharmacia1984-1997
- Sofinnova Investments · Executive Partner, Private EquityNow
Investments named in public bios
Focus
Education
Also at Sofinnova Investments
Partners like Lars
At firms with a similar stage, sector and check size.
Alert me when Sofinnova Investments is active
One email when Lars's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Lars Ekman?
Lars Ekman is an Executive Partner at Sofinnova Investments with over 30 years in life sciences. He has held senior R&D roles at Elan, Schwarz Pharma, and Pharmacia, and currently chairs Prothena.
How much does Lars Ekman invest?
Lars Ekman invests through Sofinnova Investments, which writes checks of $10M to $30M at series a, series b.
How do I pitch Lars Ekman?
Email [email protected], the firm's inbox for founders, and name Lars in the subject. A warm intro from a founder Sofinnova Investments backed works better.
What did Lars Ekman do before Sofinnova Investments?
senior scientific and clinical functions at Pharmacia; Executive Vice President, Research and Development at Schwarz Pharma AG; President of Research and Development at Elan; Pharmacia.
Last updated 2026-10-15. Is this you? Ask for a correction.